Transcription of RP-HPLC method development and validation for estimation ...
{{id}} {{{paragraph}}}
*Correspondence: S. Alt n z. Hacettepe University, Faculty of Phar-macy, Department of Analytical Chemistry. 06100 - Ankara- Turkey. E-mail: Journal of Pharmaceutical Sciencesvol. 49, n. 2, , 2013RP- hplc method development and validation for estimation of rivaroxaban in pharmaceutical dosage formsMustafa elebier, Tuba Re ber, Engin Ko ak, Sacide Alt n z*Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, TurkeyRivaroxaban, an anti-clotting medication, acts at a crucial point in the blood-clotting process and stops the formation of blood clots.
RPHPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms 361 to 1000 µL by adding water. The concentration of RIV
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
HPLC Method Development and Validation of, HPLC method, Development and validation of HPLC method, Development and Validation of Related Substances Method, HPLC, Development and validation, Development and validation of RP-HPLC method, Strategic Considerations for ffoorr for Successful, Method, Method Development, Validation, Stability indicating quantitative RP, RESEARCH AND DEVELOPMENT M. PHARM THESIS 2011